Human TCL1A Ready-To-Use IHC Kit Size:50 Test Chromogranin A precursor

Chromogranin A precursor

CD63 expression can be used to predict prognosis in early-stage carcinomas and is identical to the melanoma-associated antigen ME491 and the platelet antigen PTLGP40

Conjugation None Clone# Yeda patent Anti-MMP-9 Formulation 100 mM Pro-Ac 20mM Arg pH 5

Human IRF4 Ready-To-Use IHC Kit

thus protecting mammals from ultraviolet-induced malignant transformation and hence the prevention of skin cancer

Human TCL1A Ready-To-Use IHC Kit Size:50 Test Chromogranin A precursorHuman TCL1A Ready To Use IHC Kit Cat. No.: IHC0584H Sample Type: FFPE tissue Size: 50T (including a control slide) Storage and Stability: Please store components at the temperatures indicated on the individual tube labels. The kit is stable for 6 months from the date of receipt. Background Overexpression of the TCL1 gene in humans has been implicated in the development of mature T cell leukemia, in which chromosomal rearrangements bring the TCL1 gene